Nephros, Inc.

US$2.79As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NEPHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 0.97%
Div yield —
ROE 16.95%
Medical Instruments & Supplies
Beta (5Y) 1.75
PE TTM 15.70
TSR TTM (51.05%)
Mkt cap US$30.30M
ROIC 21.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.43
23.00%
70.53%
Hold 5|5|4|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
13.74%
17.23%
14.22%
15.26%
Revenue$M
2.622
2.711
2.696
2.656
3.65%
6.97%
7.45%
1.16%
Peers (US$30.30M)
Cap (US$)
PE
49.33M
7.920x
29.65M
11.55x
Capital
TTM
5Y
10Y
Leveragex
0.403
0.048
0.053
EBIT/Intx
1.849
0.121
0.124
Own earn%
35.99
2.88
(1.61)
Sh yield%
31.84
36.32
35.75
Owners
Insiders/Inst%
0.52
71.66
Short interest%
0.83
SBC / revenue%
3.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
5